, Les oeuvres d'Ambroise Paré, 1664.
«An exampleof Symptoms resembling Tic Douloureux, produced by a wound in the radial nerve,» The medical and physical journal, vol.31, p.1814 ,
, Gunshot wounds and other injuries of nerves, 1864.
Injuries of nerves and their consequences, Philadelphie: J.B. Lippincott & Co, 1872. ,
«Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues,» Clinical Cases in Mineral and Bone Metabolism, vol.12, pp.4-10, 2015. ,
«De la causalgie envisagée comme une névrite du sympathique et de son traitement par la dénudation et l'excision des plexus nerveux péri-artériels,» La presse médicale, vol.23, pp.178-180, 1916. ,
«Complex regional pain syndrome type I: incidence and prevalence in Olmsted country, a population-based study, » Pain, vol.103, pp.199-207, 2003. ,
«The incidence of complex regional pain syndrome: a population-based study, » Pain, vol.129, pp.12-20, 2007. ,
«Epidemiology of complex regional pain syndrome: a retrospective chart review of 150 Korean patients, Journal of Korean Medical Science, vol.23, pp.772-775, 2008. ,
«Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients, » Lancet, vol.342, p.114, 1993. ,
«Complex regional pain syndrome, Journal of Neurology, vol.252, pp.131-138, 2005. ,
«Long-term skin temperature measurements-a practical diagnostic tool in complex regional pain syndrome, » Pain, vol.140, pp.8-22, 2008. ,
, «The natural history of complex regional pain syndrome, vol.25, pp.273-280, 2009.
, Pain Medicine, vol.11, pp.1274-1277, 2010.
«Onset and progression of dystonia in complex regional pain syndrome, » Pain, vol.130, pp.287-293, 2007. ,
«Mechanism-based treatment in complex regional pain syndromes, Nature Reviews Neurology, vol.10, pp.518-528, 2014. ,
«Diagnosis of complex regional pain syndrome: signs, symptoms, and new empirically derived diagnostic criteria, Clinical Journal of Pain, vol.22, pp.415-419, 2006. ,
Classification of chronic pain, descriptions of chronic pain syndromes and definitions of pain terms, 1994. ,
«Complex regional pain syndrome type I: use of the International Association for the Study of Pain diagnostic criteria defined in 1994, The Clinical Journal of Pain, vol.18, pp.207-2015, 2002. ,
«Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?, » Pain, vol.83, p.115, 1999. ,
«External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain, » Pain, vol.81, pp.147-154, 1999. ,
, «Critères diagnostiques du syndrome douloureux régional complexe (SDRC),» Douleur et analgésie, vol.27, pp.62-64, 2014.
«Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome, » Pain, vol.150, pp.268-274, 2010. ,
«IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain, The Clinical Journal of Pain, vol.14, pp.48-54, 1998. ,
, «Les algodystrophies: aspects clinques et diagnostiques,» La lettre du rhumatologue, vol.262, pp.29-36, 2000.
«Imaging in early posttraumatic complex regional pain syndrome: a comparison of diagnostic methods, The Clinical Journal of Pain, vol.23, pp.449-457, 2007. ,
«Treatment of reflex sympathetic dystrophy of the hand with an active "stress loading" program, The Journal of Hand Surgery, vol.12, pp.779-785, 1987. ,
«The place of occupational therapy in rehabilitation strategies of complex regional pain syndrome: Comparative study of 60 cases, » Hand Surgery and Rehabilitation, vol.35, pp.355-362, 2016. ,
, «Altération des référentiels spatiaux dans le SDRC: nouveaux concepts et perspectives thérapeutiques,» Kinésithérapie scientifique, vol.552, p.116, 2014.
, Mayo Clinic Proceedings, vol.77, pp.174-180, 2002.
«Physical therapy and rehabilitation of complex regional pain syndrome in shoulder prosthesis, » The Korean Journal of Pain, vol.23, pp.258-261, 2010. ,
«Treatment of complex regional pain syndrome: functional restoration, The Clinical Journal of Pain, vol.22, pp.420-424, 2006. ,
Imagerie mentale thérapie en miroir: applications en rééducation, Montpellier: Sauramps médical, 2012. ,
, Neurology, vol.67, pp.2129-2134, 2006.
«Complex regional pain syndrome: practical diagnostic and treatment guidelines, Pain Medicine, vol.14, pp.180-229, 2013. ,
«The reflex dystrophy syndrome response to treatment with systemic corticosteroids, Acta Chirurgica Scandinavica, vol.148, pp.653-655, 1982. ,
«The shoulder-hand syndrome after stroke: a prospective clinical trial, Annals of Neurology, vol.36, pp.728-733, 1994. ,
«Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial, » QJM, vol.99, pp.89-95, 2006. ,
«The effect of gabapentin in earlier stage of reflex sympathetic dystrophy, Clinical Rheumatology, vol.26, pp.561-565, 2007. ,
, BMC Neurology, vol.29, pp.4-13, 2004.
«The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study, Anesthesia & Analgesia, vol.92, pp.488-495, 2001. ,
«A brief history of antidepressant drug development: from tricyclics to beyond ketamine, » Acta Neuropsychiatrica, vol.1, pp.1-16, 2018. ,
«Review of antidepressants in the treatment of neuropathic pain, Mental Health Clinician, vol.5, pp.123-133, 2015. ,
«Tricyclic antidepressants as long-acting local anesthetics, » Pain, vol.103, pp.49-55, 2003. ,
, «Venlafaxine versus imipramine in painful polyneuropathy: a randomized, vol.60, pp.1284-1289, 2003.
, » Drugs, vol.21, pp.257-272, 1981.
Pharmacologie-3e édition: Des cibles à la thérapeutique, DUNOD, 2014. ,
Kanis, «The use of nasal calcitonin in the treatment of posttraumatic algodystrophy, » British Journal of Rheumatology, vol.30, pp.291-294, 1991. ,
«The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy, » Pain, vol.48, pp.171-175, 1992. ,
«Efficacy of salmon calcitonin in complex 118 regional pain syndrome (type 1) in addition to physical therapy, Clinical Rheumatology, vol.25, pp.143-148, 2006. ,
«The effect of Ketamine infusion in the treatment of complex regional pain syndrome: a systemic review and Meta-analysis, » Current Pain and Headache Reports, vol.22, p.12, 2018. ,
«Treatment of complex regional pain syndrome: a review of the evidence, Canadian Journal of Anesthesia, vol.57, pp.149-166, 2010. ,
Furnish, «Lenalidomide and thalidomide in the treatment of chronic pain, Expert Opinion on Drug Safety, vol.12, pp.367-374, 2013. ,
«Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review, » Pain Physician, vol.14, pp.419-424, 2011. ,
Manuel pratique d'algologie: Prise en charge de la douleur chronique, 2017. ,
, EMC Anesthésie-Réanimation, vol.1, pp.227-266, 2004.
, données récentes,» Néphrologie, vol.24, pp.401-407, 2003.
, , 2005.
«Intracellular signaling in primary sensory neurons and persistent pain, » Neurochemical Research, vol.33, pp.1970-1978, 2008. ,
, «Nocicepteurs et médiateurs dans la douleur aiguë inflammatoire,» Annales Francaises d'Anesthésie et de Réanimation, vol.21, p.119, 2002.
, British Journal of Anesthesia, vol.75, pp.125-131, 1995.
«Posttranslational mechanisms of peripheral sensitization, Developmental Neurobiology, vol.61, pp.88-106, 2004. ,
DOI : 10.1002/neu.20083
«Prostaglandin E2 and pain-an update, » Biological and Pharmaceutical Bulletin, vol.34, pp.1170-1173, 2011. ,
DOI : 10.1248/bpb.34.1170
URL : https://www.jstage.jst.go.jp/article/bpb/34/8/34_8_1170/_pdf
«NGF-the TrkA to successful pain treatment, Journal of Pain Research, vol.2012, issue.5, pp.279-287, 2012. ,
DOI : 10.2147/jpr.s33408
URL : https://doi.org/10.2147/jpr.s33408
«Signalling pathways involved in the sensitistion of mouse nociceptive neurones by nerve growth factor, The Journal of Physiology, vol.551, pp.433-446, 2003. ,
, Biologie Aujourd'hui, vol.208, pp.21-29, 2014.
«Central sensitization: Implications for the diagnosis and treatment of pain, » Pain, vol.152, pp.2-15, 2011. ,
«Central sensitization: a generator of pain hypersensitivity by central neural plasticity, Journal of pain, vol.10, pp.895-926, 2009. ,
DOI : 10.1016/j.jpain.2009.06.012
URL : http://europepmc.org/articles/pmc2750819?pdf=render
«Protéine-tyrosine kinases de la famille Src dans le système nerveux central, » Médecine/Sciences, vol.13, pp.1106-1112, 1997. ,
DOI : 10.4267/10608/518
«Regulation of NMDA receptors by phosphorylation, » Neuropharmacology, vol.53, pp.362-368, 2007. ,
, SDRC Syndrome douloureux régional complexe, 2013.
«Role of adrenergic transmitters and receptors in nerve and tissue injury related pain,» Mechanisms and Mediators of Neuropathic Pain, pp.153-120 ,
«Complex regional pain syndrome: mystery explained, The Lancet Neurology, vol.2, pp.687-697, 2003. ,
«Patterns of cortical reorganization in complex regional pain syndrome, » Neurology, vol.23, pp.1707-1715, 2003. ,
«Cortical reorganization during recovery from complex regional pain syndrome, » Neurology, vol.63, pp.693-701, 2004. ,
«Clinical features and pathophysiology of complex regional pain syndrome, » Neurology, vol.63, pp.693-701, 2004. ,
DOI : 10.1016/s1474-4422(11)70106-5
URL : http://europepmc.org/articles/pmc5511749?pdf=render
«The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions, » Neuron, vol.60, pp.570-581, 2008. ,
«An update on the pathophysiology of complex regional pain syndrome, » Anesthesiology, vol.113, pp.713-725, 2010. ,
, Breast Cancer Research, vol.4, pp.30-34, 2002.
, Orthopedic Surgery, p.8, 2012.
«Bisphosphonates: mode of action and pharmacology, Pediatrics, vol.119, pp.150-162, 2007. ,
«Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases, Journal of Musculoskeletal and Neuronal Interactions, vol.7, p.121, 2007. ,
«Cellular and molecular mechanisms of action of bisphosphonates, » Cancer, vol.88, pp.2961-2978, 2000. ,
«Bisphosphonates: Mechanism of action and role in clinical practice, Mayo Clinic Proceedings, vol.83, pp.1032-1045, 2008. ,
, «Bisphosphonates. From bench to bedside,» The New York Academy of Sciences, vol.1068, pp.367-401, 2006.
«Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow, Journal of Clinical Investigation, vol.83, pp.1930-1935, 1989. ,
«Two modes of action of bisphosphonates on octeoclastic resorption of mineralized matrix, Bone and Mineral, vol.1, pp.27-39, 1986. ,
«Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate, Journal of Bone and Mineral Research, vol.3, pp.185-192, 1988. ,
«Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models, » Bone, vol.16, pp.235-245, 1995. ,
, «Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy, vol.5, pp.31-40, 1990.
«Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures, » Bone, vol.18, pp.9-14, 1996. ,
, , p.122
, Calcified Tissue International, vol.63, pp.143-147, 1998.
«Human osteoclast formation and activity in vitro: effects of alendronate, Journal of Bone and Mineral Research, vol.13, pp.1721-1729, 1998. ,
«Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo, Journal of Bone and Mineral Research, vol.10, pp.1478-1487, 1995. ,
«Characteristics of clodronateinduced apoptosis in osteoclasts and macrophages, Molecular Pharmacology, vol.50, pp.1127-1138, 1996. ,
«Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity, » British Journal of Haematology, vol.98, pp.665-672, 1997. ,
«Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro, The Journal of Clincal Investigation, vol.85, pp.456-461, 1990. ,
«Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure, The Journal of Clinical Investigation, vol.88, pp.2095-2105, 1991. ,
«A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders, Bone, vol.17, pp.137-144, 1995. ,
«Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate, Proceedings of the National Academy of Sciences of the United States of America, vol.93, pp.3068-3073, 1996. ,
«Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts, Bone, vol.20, pp.399-404, 1997. ,
«Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae, Molecular Pharmacology, vol.47, pp.398-402, 1995. ,
«Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum, » Biochemical and Biophysical Research Communications, vol.189, pp.414-423, 1992. ,
«The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis, Arthritis and Rheumatism, vol.44, pp.2201-2210, 2001. ,
«Biochemical and molecular mechanisms of action of bisphosphonates, » Bone, vol.49, pp.34-41, 2011. ,
«Novel aspects of mevalonate pathway inhibitors as antitumor agents, Clinical Cancer Research, vol.18, pp.3524-3531, 2012. ,
, «Modifiactions post-traductionnelles des protéines par les lipides,» Médicine/Sciences, vol.10, pp.65-73, 1994.
DOI : 10.4267/10608/2481
URL : http://www.ipubli.inserm.fr/bitstream/10608/2481/1/MS_1994_1_65.pdf
, Pharmacogenetics and Genomics, vol.21, pp.50-53, 2011.
,
,
,
«The molecular mechanism of nitrogencontaining bisphosphonates as antiosteoporosis drugs, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.7829-7834, 2006. ,
«The regulation of osteoclast function and bone resorption by small GTPases, Small GTPases, vol.2, pp.117-130, 2011. ,
«Introduction à la signalisation cellulaire, 2013. ,
,
«G protein Beta-Gamma subunits: central mediators of G proteincoupled receptor signaling, » Cellular and Molecular Life Sciences, vol.65, pp.2191-2214, 2008. ,
, Brain Research Reviews, vol.60, pp.135-148, 2009.
«Adverse effects of bisphosphonates: implications for osteoporosis management, Mayo Clinic Proceedings, vol.84, pp.632-637, 2009. ,
«Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study, vol.77, pp.1044-1052, 2002. ,
«Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group, JAMA, vol.282, p.125, 1999. ,
«Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis, Journal of Bone and Mineral Research, vol.19, pp.1241-1249, 2004. ,
«Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis, The New England Journal of Medicine, vol.356, pp.1809-1822, 2007. ,
«Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study, Arthritis and Rheumatism, vol.54, pp.1838-1846, 2006. ,
«Fever after zoledronic acid administrationis due to increase in TNF-alpha and IL-6, Journal of Interferon & Cytokine Research, vol.23, pp.649-654, 2003. ,
«Bisphosphonate-associated osteonecrosis of the jaw, Canadian Family Physician, vol.54, pp.1019-1021, 2008. ,
«Risk of atrial fibrillation with use of oral and intravenous bisphosphonates, The American Journal of Cardiology, vol.113, pp.1815-1821, 2014. ,
«Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications,» Therapeutic Advances in Chronic disease, vol.6, pp.185-193, 2015. ,
, «Bisphosphonates: A review of their pharmacokinetic properties,» Bone, vol.18, pp.75-85, 1996.
, Actualités Pharmaceutiques, vol.53, p.126, 2014.
«Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture, » Pain, vol.153, pp.1187-1192, 2012. ,
«Outcome of the complex regional pain syndrome, The Clinical Journal of Pain, vol.25, pp.590-597, 2009. ,
«Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients, » Pain, vol.80, pp.539-544, 1999. ,
«Efficacy of pamidronate in complex regional pain syndrome type I, » Pain Medicine, vol.5, pp.276-280, 2004. ,
«Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity, Arthritis and Rheumatism, vol.50, pp.3690-3697, 2004. ,
«Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases, » Rheumatology, vol.40, pp.1394-1397, 2001. ,
«Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study, » Rheumatology, vol.52, pp.534-542, 2013. ,
, «Treatment of refractory reflex sympathetic dystrophy with pamidronate,» Annals of the rheumatic diseases, vol.54, p.687, 1995.
, La Revue de Medecine Interne, vol.26, pp.226-232, 2005.